You have identified reliable biomarkers or designed mAb against a bio-target.
You have developed a companion diagnostic tool: immuno assay prototype (ELISA or LFIA) for biomarkers monitoring and you are willing to find a partner to industrialize your device before commercial batch.
Delpharm Biotech, as Immuno Assay contract manufacturing organization (CMO) with all the capabilities, under ISO 13485 can meet your requirement in both veterinary and human diagnostic markets.